Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$2.82 - $3.55 $51,104 - $64,333
-18,122 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$3.42 - $4.55 $61,977 - $82,455
18,122 New
18,122 $65,000
Q4 2019

Feb 14, 2020

SELL
$3.48 - $6.75 $37,584 - $72,900
-10,800 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$3.95 - $5.72 $42,660 - $61,776
10,800 New
10,800 $59,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.